Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 17/20 | 0.79 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.79 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.79 |
| ▸ | ESRRG | P62508 | 16/20 | 0.74 |
| ▸ | LMNA | P02545 | 1/20 | 0.65 |
| ▸ | HTR6 | P50406 | 1/20 | 0.65 |
| ▸ | ESRRB | O95718 | 2/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8362672 | 1.00 | ESR1 (0.79) | ESR1CYP19A1ESR2ESRRGLMNA | |
| SCHEMBL5738276 | 1.00 | ESR1 (0.79) | ESR1CYP19A1ESR2ESRRGLMNA | |
| SCHEMBL5738281 | 1.00 | ESR1 (0.79) | ESR1CYP19A1ESR2ESRRGLMNA | |
| SCHEMBL8362668 | 1.00 | ESR1 (0.79) | ESR1CYP19A1ESR2ESRRGLMNA | |
| SCHEMBL5738427 | 1.00 | ESR1 (0.79) | ESR1CYP19A1ESR2ESRRGLMNA | |
| SCHEMBL5737939 | 0.95 | LMNA (0.71) | ESR1CYP19A1ESR2ESRRGLMNA | |
| Ospemifene SCHEMBL948118 | 0.95 | LMNA (0.71) | ESR1CYP19A1ESR2ESRRGLMNA | |
| Ospemifene SCHEMBL2231997 | 0.95 | LMNA (0.71) | ESR1CYP19A1ESR2ESRRGLMNA | |
| SCHEMBL8362689 | 0.95 | ESR1 (0.70) | ESR1CYP19A1ESR2ESRRGLMNA | |
| SCHEMBL8362685 | 0.95 | ESR1 (0.70) | ESR1CYP19A1ESR2ESRRGLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114392276-B | Anti-aging medicine prepared from improved anti-aging umbilical cord stem cells | 河北意和医学检验实验室有限公司 | 2023-10-03 | — | — | CN | claimed |
| CN-114392276-A | Anti-aging medicine prepared from improved anti-aging umbilical cord stem cells and related cosmetic products | 北京岳淘生物科技有限公司 | 2022-04-26 | — | — | CN | claimed |
| CN-114392276-B | Anti-aging medicine prepared from improved anti-aging umbilical cord stem cells | 河北意和医学检验实验室有限公司 | 2023-10-03 | — | — | CN | disclosed |
| CN-114504598-B | Application of umbilical cord stem cells in preparation of anti-aging drugs | 前沿外泌体(珠海横琴)生物医药研发有限公司 | 2023-08-22 | — | — | CN | disclosed |
| CN-114504598-A | Application of umbilical cord stem cells in preparation of anti-aging drugs and related beauty products | 北京岳淘生物科技有限公司 | 2022-05-17 | — | — | CN | disclosed |
| CN-114392276-A | Anti-aging medicine prepared from improved anti-aging umbilical cord stem cells and related cosmetic products | 北京岳淘生物科技有限公司 | 2022-04-26 | — | — | CN | disclosed |
| US-8642079-B2 | Solid formulations of ospemifene | HORMOS MEDICAL CORPORATION (FI) | 2014-02-04 | — | — | US | disclosed |
| US-8642079-B2 | Solid formulations of ospemifene | HORMOS MEDICAL CORPORATION (FI) | 2014-02-04 | — | — | US | disclosed |
| EP-2286806-A1 | Solid formulations of ospemifene | Hormos Medical Ltd. (FI) | 2011-02-23 | — | — | EP | disclosed |
| EP-0779808-B1 | TRIPHENYLETHYLENES FOR THE PREVENTION AND TREATMENT OF OSTEOPOROSIS | ORION YHTYMAE OY (FI) | 1999-08-18 | — | — | EP | disclosed |